A signaling factor called Wnt10b is a novel target for optimizing cardiac repair after a heart attack.

The initial results of a landmark clinical trial sponsored by the National Institutes of Health (NIH) indicate lowering systolic blood pressure below a commonly recommended target significantly reduces rates of cardiovascular events and lowers risk of death in a group of adults 50 years and older.

The Vanderbilt Kennedy Center (VKC) has been awarded a $6.5 million, five-year grant to continue as a national Eunice Kennedy Shriver Intellectual and Developmental Disabilities Research Center (IDDRC).

Vanderbilt University researchers have received two major federal grants — totaling $7.6 million over four years — to support groundbreaking research aimed at making genetic information a routine part of patients’ electronic medical records.

Kiersten Eaddy had long looked forward to her high school graduation day and joining her classmates to celebrate the accomplishment.

The Vanderbilt Institute for Clinical and Translational Research (VICTR) is partnering with a public charity, Cures Within Reach, to encourage “rediscovery research,” the “repurposing” of already approved medical treatments to other conditions or diseases for which there are no “universally” effective therapies.

Two faculty members of the Vanderbilt Memory and Alzheimer’s Center are among a handful of 2015 scholars for the Paul B. Beeson Career Development Awards in Aging Research Program.